Quality of life (QoL) during first-line treatment with FOLFOX4 with or without panitumumab (pmab) in RAS wild-type (WT) metastatic colorectal carcinoma (mCRC).
- Resource Type
- Journal
- Source
JOURNAL OF CLINICAL ONCOLOGY ; JAN 20 2015, 33 3, 1p. Supplement: S- Subject
- Language
- English
- ISSN
- 15277755